System and method for applying therapy during hyperpnea phase of periodic breathing using an implantable medical device

• US 7,082,331 B1
• Filed: 04/21/2004
• Issued: 07/25/2006
• Est. Priority Date: 04/21/2004
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Benser, Michael, Park, Euljoon
• Primary Examiner(s): Pezzuto, Robert E.
• Assistant Examiner(s): Gedeon, Brian T.
• Application Number:
  US10/830,357
• Time in Patent Office: 825 Days
• Field of Search: 607/2, 607/42, 607/48, 607/47, 600/529, 128/204.18
• US Class Current: 607/42
• CPC Class Codes: A61N 1/3601 of respiratory organs

Abstract

Techniques are provided for treating periodic breathing, such as Cheyne-Stokes Respiration, using an implantable medical system. In one technique, diaphragmatic stimulation is delivered during a hyperpnea phase of periodic breathing via electrical stimulation of the phrenic nerves. Diaphragmatic stimulation is synchronized with intrinsic inspiration so as to increase the amplitude of diaphragmatic contraction during inspiration. This tends to decrease intrathoracic pressure leading to occlusion of the respiratory airway. Occlusion reduces actual ventilation during hyperpnea, thus reducing the cyclic blood chemistry imbalance that sustains periodic breathing so as to either mitigate periodic breathing or eliminate it completely. In another technique, respiration is instead inhibited during the hyperpnea phase of periodic breathing by blocking phrenic nerve signals to the extent necessary to reduce ventilation to terminate periodic breathing or at least mitigate its severity. Techniques are also described for controlling the type of therapy applied in response to periodic breathing.

Claims

1. A method for delivering therapy in response to periodic breathing within a patient using an implantable medical system, the method comprising:

detecting periods of hyperpnea during periodic breathing; and

selectively inhibiting respiration during the periods of hyperpnea.

2. The method of claim 1 wherein respiration is inhibited during the periods of hyperpnea by an amount sufficient to mitigate periodic breathing.

3. The method of claim 1 wherein the respiration is inhibited in response to periods of hyperpnea occurring during Cheyne-Stokes Respiration.

4. The method of claim 1 wherein an implantable phrenic nerve inhibitor is provided and wherein inhibiting respiration during hyperpnea is performed by selectively blocking intrinsic nerve signals propagating along the phrenic nerves of the patient during the periods of hyperpnea.

5. The method of claim 1 further comprising determining whether frank apnea is occurring during the hypopnea periods of the periodic breathing and wherein respiration inhibition is performed during the periods of hyperpnea only if frank apnea is found to occur during the during the hypopnea periods.

6. The method of claim 5 wherein, if frank apnea is not found to occur during the hypopnea periods of periodic breathing, diaphragmatic stimulation is instead delivered during the periods of hypopnea, including during any non-frank episodes of apnea occurring therein.

7. The method of claim 6 wherein an implantable phrenic nerve stimulator is provided and wherein delivering diaphragmatic stimulation during periods of hypopnea is performed by selectively delivering electrical nerve stimulation to the phrenic nerves of the patient.

8. The method of claim 7 wherein diaphragmatic stimulation delivered during periods of hypopnea is synchronized with any intrinsic respiration during the hypopnea.

9. An implantable medical system for delivering therapy in response to periodic breathing within a patient, the system comprising:

a periodic breathing detection system operative to detect episodes of periodic breathing and to identify periods of hyperpnea therein; and

a hyperpnea-based respiration inhibition system operative to selectively inhibit respiration during the periods of hyperpnea.

10. The implantable medical system of claim 9 wherein the respiration inhibition system comprises an implantable phrenic nerve inhibitor operative to block intrinsic nerve signals propagating along the phrenic nerves of the patient during the periods of hyperpnea.

11. An implantable medical system for delivering therapy in response to periodic breathing within a patient, the system comprising;

a periodic breathing detection system operative to detect episodes of periodic breathing and to identify periods of hyperpnea and hypopnea therein; and

a periodic breathing severity evaluation system operative to detect episodes of frank apnea, if any, occurring during the periods of hypopnea;

a hyperpnea-based respiration inhibition system operative to selectively inhibit respiration during the periods of hyperpnea if frank apnea is found to occur during the periods of hypopnea; and

a hypopnea-based diaphragmatic stimulation system operative to selectively deliver diaphragmatic stimulation during the periods of hypopnea if frank apnea is not found to occur during the periods of hypopnea.

12. The implantable medical system of claim 11 wherein the respiration inhibition system comprises an implantable phrenic nerve inhibitor operative to block intrinsic nerve signals propagating along the phrenic nerves of the patient during the periods of hyperpnea.